Robert T Foster - Net Worth and Insider Trading
Robert T Foster Net Worth
The estimated net worth of Robert T Foster is at least $64,097 dollars as of 2024-06-05. Robert T Foster is the CEO and Director of Hepion Pharmaceuticals Inc and owns about 50,470 shares of Hepion Pharmaceuticals Inc (HEPA) stock worth over $64,097. Details can be seen in Robert T Foster's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert T Foster has not made any transactions after 2023-09-18 and currently still holds the listed stock(s).
Transaction Summary of Robert T Foster
Robert T Foster Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert T Foster owns 2 companies in total, including Hepion Pharmaceuticals Inc (HEPA) , and Aurinia Pharmaceuticals Inc (AUPH) .
Click here to see the complete history of Robert T Foster’s form 4 insider trades.
Insider Ownership Summary of Robert T Foster
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HEPA | Hepion Pharmaceuticals Inc | 2023-09-18 | Chief Scientific Officer |
| AUPH | Aurinia Pharmaceuticals Inc | 2023-09-21 | director |
Robert T Foster Latest Holdings Summary
Robert T Foster currently owns a total of 1 stock. Robert T Foster owns 50,470 shares of Hepion Pharmaceuticals Inc (HEPA) as of September 18, 2023, with a value of $64,097.
Latest Holdings of Robert T Foster
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HEPA | Hepion Pharmaceuticals Inc | 2023-09-18 | 50,470 | 1.27 | 64,097 |
Holding Weightings of Robert T Foster
Robert T Foster Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert T Foster has made a total of 4 transactions in Hepion Pharmaceuticals Inc (HEPA) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Hepion Pharmaceuticals Inc is the acquisition of 1,600 shares on September 18, 2023, which cost Robert T Foster around $8,960.
Insider Trading History of Robert T Foster
- 1
Robert T Foster Trading Performance
GuruFocus tracks the stock performance after each of Robert T Foster's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert T Foster is -19.37%. GuruFocus also compares Robert T Foster's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert T Foster within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert T Foster's insider trading performs compared to the benchmark.
Performance of Robert T Foster
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.72 | | | | | |
| Relative Return to S&P 500(%) | -2.09 | | | | | |
Robert T Foster Ownership Network
Robert T Foster Owned Company Details
What does Hepion Pharmaceuticals Inc do?
Who are the key executives at Hepion Pharmaceuticals Inc?
Robert T Foster is the Chief Scientific Officer of Hepion Pharmaceuticals Inc. Other key executives at Hepion Pharmaceuticals Inc include Chief Financial Officer John T Cavan , director & CEO and President Gary S Jacob , and 10 percent owner Donald E Garlikov .
Hepion Pharmaceuticals Inc (HEPA) Insider Trades Summary
Over the past 18 months, Robert T Foster made 2 insider transaction in Hepion Pharmaceuticals Inc (HEPA) with a net purchase of 3,200. Other recent insider transactions involving Hepion Pharmaceuticals Inc (HEPA) include a net purchase of 8,000 shares made by Peter Wijngaard ,
In summary, during the past 3 months, insiders sold 0 shares of Hepion Pharmaceuticals Inc (HEPA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Hepion Pharmaceuticals Inc (HEPA) were sold and 11,200 shares were bought by its insiders, resulting in a net purchase of 11,200 shares.
Hepion Pharmaceuticals Inc (HEPA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Hepion Pharmaceuticals Inc Insider Transactions
Robert T Foster Mailing Address
Above is the net worth, insider trading, and ownership report for Robert T Foster. You might contact Robert T Foster via mailing address: C/o Contravir Pharmaceuticals, Inc., 399 Thornall Street, First Floor, Edison Nj 08837.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
